Bristol-Myers Squibb (BMY) News Today $57.33 +1.03 (+1.83%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Principal Financial Group Inc.Principal Financial Group Inc. raised its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 4.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,458,536 shares of the biopharmaceutical company's stock after acqDecember 21 at 4:56 AM | marketbeat.comWant Decades of Passive Income? 3 Stocks to Buy Right NowDecember 21 at 4:24 AM | fool.comM&T Bank Corp Reduces Holdings in Bristol-Myers Squibb (NYSE:BMY)M&T Bank Corp cut its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 4.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 901,347 shares of the biopharmaceutical company's stock after selling 42December 21 at 4:10 AM | marketbeat.comBristol-Myers Squibb: Rich Dividends & Double-Digits Upside Potential - Bright 2026 ProspectsDecember 20 at 2:45 PM | seekingalpha.comBristol Myers enters $100M PyroGlu-Ass license agreement with BioArcticDecember 20 at 2:14 PM | markets.businessinsider.comBristol-Myers Squibb: Rich Dividends & Double-Digits Upside Potential - Bright 2026 ProspectsDecember 20 at 2:14 PM | seekingalpha.comBristol-Myers Squibb Will Handle The Patent Cliff And Is Still UndervaluedDecember 20 at 8:17 AM | seekingalpha.comJim Cramer on Bristol-Myers Squibb Company (BMY): ‘This Stock Has Been Hot Since The Summer’December 19 at 11:42 PM | insidermonkey.com3 High-Yielding Dividend Stocks That Retirees Can Rely On for Recurring IncomeDecember 19 at 10:00 AM | fool.comImbed Biosciences Appoints Bristol Myers Squibb Veteran Terry Bromley as Chief Executive OfficerDecember 19 at 8:30 AM | businesswire.comBristol-Myers Squibb Co (BMY) to Announce Q4 2024 Financial ResultsDecember 19 at 7:08 AM | gurufocus.comGot $250? 2 Healthcare Stocks to Buy and Hold ForeverDecember 19 at 6:15 AM | fool.comThese 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?December 19 at 5:26 AM | fool.comBioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody programDecember 19 at 1:48 AM | prnewswire.comFangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet HealthcareDecember 18, 2024 | prnewswire.comIs Bristol-Myers Squibb Company (BMY) the Best Cash-Rich Dividend Stock to Invest In Now?December 18, 2024 | insidermonkey.comBristol-Myers: Still An Opportunity Yielding Over 4%December 18, 2024 | seekingalpha.comBristol-Myers Squibb (NYSE:BMY) Raised to "Buy" at Jefferies Financial GroupDecember 18, 2024 | americanbankingnews.comIs Bristol-Myers Squibb Company (BMY) the Best Weight Loss Stock to Buy Now According to Hedge Funds?December 17, 2024 | insidermonkey.comJefferies Upgrades Bristol Myers Squibb to ‘buy’ on drug CobenfyDecember 17, 2024 | msn.comJefferies Upgrades Bristol-Myers Squibb (BMY)December 17, 2024 | msn.comBristol-Myers Squibb Shares Rise After Analyst Upgrades, Positive Pipeline OutlookDecember 16, 2024 | benzinga.comBristol Myers upgraded to Buy at Jefferies on new launch momentum, pipelineDecember 16, 2024 | markets.businessinsider.comJefferies Financial Group Upgrades Bristol-Myers Squibb (NYSE:BMY) to BuyJefferies Financial Group upgraded shares of Bristol-Myers Squibb from a "hold" rating to a "buy" rating and set a $70.00 price target on the stock in a report on Monday.December 16, 2024 | marketbeat.comWellington Management Group LLP Sells 16,518 Shares of Bristol-Myers Squibb (NYSE:BMY)Wellington Management Group LLP trimmed its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 9.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 150,188 shares of the biopharmaceuDecember 16, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Will Pay A Larger Dividend Than Last Year At $0.62December 15, 2024 | finance.yahoo.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Franklin Resources Inc.Franklin Resources Inc. trimmed its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 38.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,563,853 shares of the biopharmaceutical company's stock after sellinDecember 15, 2024 | marketbeat.comExome Asset Management LLC Invests $4.04 Million in Bristol-Myers Squibb (NYSE:BMY)Exome Asset Management LLC bought a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The firm bought 78,000 shares of the biopharmaceutical company's stock, valued at approximately $4,036,000. BrDecember 14, 2024 | marketbeat.comTidal Investments LLC Sells 19,338 Shares of Bristol-Myers Squibb (NYSE:BMY)Tidal Investments LLC decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 13.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 125,350 shares of the biopharmaceutical coDecember 14, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Receives Consensus Rating of "Hold" from BrokeragesShares of Bristol-Myers Squibb (NYSE:BMY - Get Free Report) have earned a consensus recommendation of "Hold" from the twenty brokerages that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating, twoDecember 14, 2024 | marketbeat.comBristol Myers Squibb (BMY) Stock Moves -0.89%: What You Should KnowDecember 14, 2024 | msn.comCentury Therapeutics Faces Termination of BMS AgreementDecember 13, 2024 | tipranks.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Retirement Systems of AlabamaRetirement Systems of Alabama reduced its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 6.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,412,387 shares of the biopharmaceutical company's stock aDecember 13, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Acquired by Inspire Trust Co. N.A.Inspire Trust Co. N.A. lifted its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 39.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 103,500 shares of the biopharmaceutical company's stock after purchasing an additional 2December 13, 2024 | marketbeat.comPeapack Gladstone Financial Corp Sells 70,311 Shares of Bristol-Myers Squibb (NYSE:BMY)Peapack Gladstone Financial Corp decreased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 12.5% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 493,031 shares of the biopharmaceutical company's stock after selling 70,31December 13, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Bought by Wilmington Savings Fund Society FSBWilmington Savings Fund Society FSB grew its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 85.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 159,681 shares of the biopharmaceutical company's stock afterDecember 13, 2024 | marketbeat.comSanctuary Advisors LLC Acquires 143,743 Shares of Bristol-Myers Squibb (NYSE:BMY)Sanctuary Advisors LLC raised its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 81.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 320,676 shares of the biopharmaceutical company's stock after purchasing an additional 143,743December 13, 2024 | marketbeat.com3 Healthcare Innovators Revolutionizing Patient CareDecember 12, 2024 | stocknews.comArvest Bank Trust Division Takes Position in Bristol-Myers Squibb (NYSE:BMY)Arvest Bank Trust Division purchased a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund purchased 33,320 shares of the biopharmaceutical company's stock, valued at approximately $1,724,000. Other large investorDecember 12, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Stock Yards Bank & Trust Co.Stock Yards Bank & Trust Co. cut its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 9.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 96,315 shares of the biopharmaceutical company's stock after sellinDecember 12, 2024 | marketbeat.comTe Ahumairangi Investment Management Ltd Sells 37,110 Shares of Bristol-Myers Squibb (NYSE:BMY)Te Ahumairangi Investment Management Ltd lowered its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 25.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 108,947 shares of tDecember 12, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Acquired by Teachers Retirement System of The State of KentuckyTeachers Retirement System of The State of Kentucky boosted its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 70.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 278,908 shares of the bioDecember 12, 2024 | marketbeat.comToronto Dominion Bank Trims Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Toronto Dominion Bank decreased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 23.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 835,084 shares of the biopharmaceutical company'sDecember 12, 2024 | marketbeat.comColdstream Capital Management Inc. Raises Stock Position in Bristol-Myers Squibb (NYSE:BMY)Coldstream Capital Management Inc. lifted its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 47.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 29,133 shares of the biopharmaceutical company'December 12, 2024 | marketbeat.comVestcor Inc Lowers Holdings in Bristol-Myers Squibb (NYSE:BMY)Vestcor Inc lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 46.9% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 38,827 shares of the biopharmaceutical company's stock after selling 34,283 shares during the period. VestcorDecember 12, 2024 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Earns "Neutral" Rating from Bank of AmericaDecember 12, 2024 | americanbankingnews.comBristol Myers raises quarterly dividend 3.3% to 62c per shareDecember 12, 2024 | markets.businessinsider.comBristol-Myers Squibb Co (BMY) Announces Increased Quarterly DividendDecember 11, 2024 | gurufocus.comBristol Myers Squibb Announces Dividend IncreaseDecember 11, 2024 | businesswire.comBerenberg Bank Remains a Hold on Bristol-Myers Squibb (BMY)December 11, 2024 | markets.businessinsider.com Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Vladimir Lenin was right… (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier. Including the name of the #1 company to buy. BMY Media Mentions By Week BMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼0.700.59▲Average Medical News Sentiment BMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼2827▲BMY Articles Average Week Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Perrigo News Today Supernus Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
